- Home
- Publications
- Publication Search
- Publication Details
Title
MABp1 for the treatment of colorectal cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 17, Issue 9, Pages 1155-1161
Publisher
Informa UK Limited
Online
2017-07-10
DOI
10.1080/14712598.2017.1347631
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advanced colorectal cancer treatment options beyond standard systemic therapy
- (2017) Timothy J Price LANCET ONCOLOGY
- MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
- (2017) Tamas Hickish et al. LANCET ONCOLOGY
- Interleukins 1 and 6 as main mediators of inflammation and cancer
- (2016) O. S. Dmitrieva et al. BIOCHEMISTRY-MOSCOW
- Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses
- (2016) Katrin D Mayer-Barber et al. Cellular & Molecular Immunology
- Novel therapeutic options for cachexia and sarcopenia
- (2016) Alessio Molfino et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase III double-blinded, placebo-controlled study of MABp1 for improving survival in metastatic colorectal cancer.
- (2016) Sanjay Goel et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous revascularization
- (2016) Hosam El Sayed et al. JOURNAL OF VASCULAR SURGERY
- Rethinking the INN system for therapeutic antibodies
- (2016) Jérémy Pottier et al. mAbs
- Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer
- (2016) R. F. Sweis et al. Cancer Immunology Research
- Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer
- (2015) David S. Hong et al. INVESTIGATIONAL NEW DRUGS
- Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus
- (2015) Katharina Timper et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Prognostic nomogram integrated systemic inflammation score for patients with esophageal squamouscell carcinoma undergoing radical esophagectomy
- (2015) Yingjie Shao et al. Scientific Reports
- Reporting of MABp1 for the Treatment of Psoriasis
- (2015) Bobbak Mansouri et al. JAMA Dermatology
- Interleukin-1α neutralisation in patients with cancer
- (2014) Charles Anthony Dinarello LANCET ONCOLOGY
- MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
- (2014) David S Hong et al. LANCET ONCOLOGY
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy
- (2013) Yizhou Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010
- (2012) Tine Jess et al. Clinical Gastroenterology and Hepatology
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Alternative End Points to Evaluate a Therapeutic Strategy in Advanced Colorectal Cancer: Evaluation of Progression-Free Survival, Duration of Disease Control, and Time to Failure of Strategy—An Aide et Recherche en Cancérologie Digestive Group Study
- (2011) Benoist Chibaudel et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
- (2011) John Burn et al. LANCET
- The value of progression-free survival to patients with advanced-stage cancer
- (2011) Lesley J. Fallowfield et al. Nature Reviews Clinical Oncology
- Cancer-related inflammation: Common themes and therapeutic opportunities
- (2011) Frances R. Balkwill et al. SEMINARS IN CANCER BIOLOGY
- Comparison of the Prognostic Value of Tumour- and Patient-Related Factors in Patients Undergoing Potentially Curative Resection of Oesophageal Cancer
- (2011) Sumanta Dutta et al. WORLD JOURNAL OF SURGERY
- Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
- (2009) John A. Lust et al. MAYO CLINIC PROCEEDINGS
- IL-1, IL-18, and IL-33 families of cytokines
- (2008) William P. Arend et al. IMMUNOLOGICAL REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now